These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 35860689)

  • 21. Bioinformatics Prediction and Experimental Verification Identify CAB39L as a Diagnostic and Prognostic Biomarker of Kidney Renal Clear Cell Carcinoma.
    Wu Y; Xu Z; Chen X; Fu G; Tian J; Shi Y; Sun J; Jin B
    Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109674
    [No Abstract]   [Full Text] [Related]  

  • 22. TACC3 is a prognostic biomarker for kidney renal clear cell carcinoma and correlates with immune cell infiltration and T cell exhaustion.
    Fan X; Liu B; Wang Z; He D
    Aging (Albany NY); 2021 Mar; 13(6):8541-8562. PubMed ID: 33714201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NCF1/2/4 Are Prognostic Biomarkers Related to the Immune Infiltration of Kidney Renal Clear Cell Carcinoma.
    Chen Y; He F; Wang R; Yao M; Li Y; Guo D; He S
    Biomed Res Int; 2021; 2021():5954036. PubMed ID: 34708124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathological and Prognostic Value of Necroptosis-Associated lncRNA Model in Patients with Kidney Renal Clear Cell Carcinoma.
    Gu J; He Z; Huang Y; Luan T; Chen Z; Wang J; Ding M
    Dis Markers; 2022; 2022():5204831. PubMed ID: 35664432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An
    Fu S; Gong B; Ding Y; Zhuang C; Chen Q; Wang S; Li Z; Ma M; Liu Y; Zhang Z; Sun T
    Comb Chem High Throughput Screen; 2022; 25(13):2278-2294. PubMed ID: 35293292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential Diagnostic and Prognostic Values of CBX8 Expression in Liver Hepatocellular Carcinoma, Kidney Renal Clear Cell Carcinoma, and Ovarian Cancer: A Study Based on TCGA Data Mining.
    Lin J; Chen L; Wu D; Lin J; Liu B; Guo C
    Comput Math Methods Med; 2022; 2022():1372879. PubMed ID: 35813444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Impact of MITD1 and Associates With Immune Infiltration in Kidney Renal Clear Cell Carcinoma.
    Chen C; Sheng Y
    Technol Cancer Res Treat; 2021; 20():15330338211036233. PubMed ID: 34346239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of RARRES1 with ICAM1 modulates macrophages to suppress the progression of kidney renal clear cell carcinoma.
    Geng X; Chi K; Liu C; Fu Z; Wang X; Meng L; Wang H; Cai G; Chen X; Hong Q
    Front Immunol; 2022; 13():982045. PubMed ID: 36353618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD72, a new immune checkpoint molecule, is a novel prognostic biomarker for kidney renal clear cell carcinoma.
    Tian L; Wang Y; Zhang Z; Feng X; Xiao F; Zong M
    Eur J Med Res; 2023 Nov; 28(1):531. PubMed ID: 37980541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COLGALT1 is a potential biomarker for predicting prognosis and immune responses for kidney renal clear cell carcinoma and its mechanisms of ceRNA networks.
    Liu S; Yu Y; Wang Y; Zhu B; Han B
    Eur J Med Res; 2022 Jul; 27(1):122. PubMed ID: 35842702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Prognostic Assessment of CDC20 in Patients with Renal Clear Cell Carcinoma and Its Relationship with Body Immunity.
    Shi J; Chen Y; Gu X; Wang X; Liu J; Chen X
    Contrast Media Mol Imaging; 2022; 2022():7727539. PubMed ID: 35800227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival Prognosis, Tumor Immune Landscape, and Immune Responses of PPP1R18 in Kidney Renal Clear Cell Carcinoma and Its Potentially Double Mechanisms.
    Wang Y; Liu S; Chen Y; Zhu B; Xing Q
    World J Oncol; 2022 Feb; 13(1):27-37. PubMed ID: 35317332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SOX11 as a prognostic biomarker linked to m6A modification and immune infiltration in renal clear cell carcinoma.
    Wang K; Chen X; Liu Y; Meng X; Zhou L
    Transl Cancer Res; 2024 Jul; 13(7):3536-3555. PubMed ID: 39145091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulated GSDMB in Clear Cell Renal Cell Carcinoma Is Associated with Immune Infiltrates and Poor Prognosis.
    Cui Y; Zhou Z; Chai Y; Zhang Y
    J Immunol Res; 2021; 2021():7753553. PubMed ID: 34957313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selection of M7G-related lncRNAs in kidney renal clear cell carcinoma and their putative diagnostic and prognostic role.
    Zhong S; Chen S; Lin H; Luo Y; He J
    BMC Urol; 2023 Nov; 23(1):186. PubMed ID: 37968670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utilizing a novel model of PANoptosis-related genes for enhanced prognosis and immune status prediction in kidney renal clear cell carcinoma.
    Jiang Z; Wang J; Dao C; Zhu M; Li Y; Liu F; Zhao Y; Li J; Yang Y; Pan Z
    Apoptosis; 2024 Jun; 29(5-6):681-692. PubMed ID: 38281281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients.
    Yu J; Mao W; Xu B; Chen M
    Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High MICAL1 expression correlates with cancer progression and immune infiltration in renal clear cell carcinoma.
    Yang Y; Ye F; Xia T; Wang Q; Du J
    BMC Cancer; 2022 Dec; 22(1):1355. PubMed ID: 36575439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dichotomous roles of ADAR1 in liver hepatocellular carcinoma and kidney renal cell carcinoma: Unraveling the complex tumor microenvironment and prognostic significance.
    Mao JX; Li JJ; Lu XY; Zhong HX; Zhao YY; Zhu LY; Fu H; Ding GS; Teng F; Chen M; Guo WY
    Int Immunopharmacol; 2024 Jul; 136():112340. PubMed ID: 38820962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the basement membrane in kidney renal clear cell carcinoma to guide clinical therapy.
    Xiong X; Chen C; Yang J; Ma L; Wang X; Zhang W; Yuan Y; Peng M; Li L; Luo P
    Front Oncol; 2022; 12():1024956. PubMed ID: 36439501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.